NAUT (Nautilus Biotechnology Inc) Operatsion marja

Ommaviy kompaniya Nautilus Biotechnology Inc (NAUT) logotipi

Operatsion marja ko'rsatkichlariga kelsak, GURU.Markets saytidagi ushbu grafik -15105.70 qiymati Nautilus Biotechnology (NAUT) uchun joriy parametr qiymati ekanligini ko'rsatmoqda. Ushbu tendentsiya R&D xarajatlarini nazorat qilish bilan birga, proteomika platformasining ishga tushirish muddatiga bog'liqlikni va chiqindilarni kamaytiradigan testlarga nisbatan ekologik toza yondashuvni aks ettiradi. Markazlar bilan hamkorlik orqali DNK tahlilining rivojlanishi saraton nishanlarini qidirishni tezlashtirib, ma'lumotlar sinergiyasini yaratmoqda.

NAUT: Nautilus Biotechnology, Inc. Sotuvning operatsion marjasi 04.07.2022 - 19.11.2026

Nautilus Biotechnology Inc (NAUT) kompaniyasining tahliliy kesimlari

Kompaniyaning fundamental tahlili:NAUT, Nautilus Bio
Nautilus Biotechnology, Inc. asosiy tovari

Fundamental ko'rsatkichlardagi salbiy dinamika yuqori xatarlarni anglatadi, bunda asosiy faoliyatdan olingan foyda ulushi soliqlar va foizlargacha bo'lgan operatsion sikl samaradorligini o'lchaydi. Nautilus Biotechnology (NAUT) uchun ushbu ko'rsatkich Proteome Analysis Platform ning joriy etilish bosqichini aks ettiradi, chunki ishlanmalar xarajatlari pilot savdolardan tushgan joriy daromadlardan yuqori bo'lib, bu grafik kompaniyaning operatsion zararsizlik nuqtasiga yetish tezligini kuzatish uchun asosiy vositaga aylanadi.

Muhim raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik